EUVIMEDEUVIMED entdecken
Crossref

Successful therapy with dupilumab for pityriasis lichenoides et varioliformis acuta

Yaxuan Zheng, Lianming Liao, Hongyu Yang, Huichun Su

European Journal of Dermatology · 2023-06 · 33 (3) · 304-305

DOI: 10.1684/ejd.2023.4483 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Dermatology, 2023-06. Verfasst von Yaxuan Zheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology and Venerology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China. Hauptthemen laut MEDLINE: Pityriasis Lichenoides. Die Arbeit wurde bisher 5-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Pityriasis LichenoidesHumansAntibodies, Monoclonal, Humanized

Substanzen

dupilumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Department of Dermatology and Venerology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China.
  • Department of Pathology, Stvincent Evansville Hosptial, Evansville, IN, 47750, USA.

Zitieren

APA

Zheng, Y., Liao, L., Yang, H., & Su, H. (2023). Successful therapy with dupilumab for pityriasis lichenoides et varioliformis acuta. European Journal of Dermatology, 33(3), 304-305. https://doi.org/10.1684/ejd.2023.4483

Vancouver

Zheng Y, Liao L, Yang H, Su H. Successful therapy with dupilumab for pityriasis lichenoides et varioliformis acuta. European Journal of Dermatology. 2023;33(3):304-305. doi:10.1684/ejd.2023.4483

BibTeX
@article{Zheng2023,
  author = {Zheng, Yaxuan and Liao, Lianming and Yang, Hongyu and Su, Huichun},
  title = {Successful therapy with dupilumab for pityriasis lichenoides et varioliformis acuta},
  journal = {European Journal of Dermatology},
  year = {2023},
  volume = {33},
  number = {3},
  pages = {304--305},
  doi = {10.1684/ejd.2023.4483}
}
Kostenlos starten →